NASDAQ · VINC
Healthcare · Biotechnology
$0.02
Up+$0.00 (+0.00%)
Updated Sep 17, 2026, 3:06 AM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
VINC does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning VINC.
VINC research
Company profile and research snapshot.
VINCERX PHARMA INC
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 8, 2024 | Leerink Partners | Outperform | — |
| Apr 9, 2024 | Cantor Fitzgerald | Overweight | — |
| Apr 1, 2024 | Cantor Fitzgerald | Overweight | — |
| Sep 7, 2023 | Cantor Fitzgerald | Overweight | — |
| Nov 17, 2022 | Chardan Capital | Buy | — |
No generated briefing is available yet.
Benzinga · Mar 18, 2025
Vincerx Pharma has entered into a non-binding letter of intent to merge with QumulusAI, a private AI infrastructure company. The proposed transaction would result in QumulusAI becoming a publicly traded company through a reverse triangular merger with Vincerx.
Benzinga · Feb 28, 2025
Vincerx Pharma has terminated its reverse merger term sheet and is now evaluating strategic alternatives, including out-licensing, mergers and acquisitions, asset sales, and winding down operations.
Zacks Investment Research · Jun 27, 2024
Vincerx Pharma (VINC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
GlobeNewswire Inc. · May 14, 2024
Vincerx continued to progress Phase 1 dose-escalation studies for VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC), and VIP236, a first-in-class small molecule-drug conjugate (SMDC)
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning VINC.
No results
No recent SID articles mention VINC.
